Lineage cell therapeutics provides update on opc1 cell therapy program for spinal cord injury

Lineage cell therapeutics, inc. (nyse american and tase: lctx), a clinical-stage biotechnology company developing novel cell therapies for unmet medic

NVIV Ratings Summary

NVIV Quant Ranking